Document:

Exhibit
10.65

AMENDMENT

THIS AMENDMENT is made as of
October 23, 2006, and amends the Employment Agreement dated as of April 2,
2004, as amended as of February 13, 2006 (collectively the “Employment
Agreement”), between DENDRITE INTERNATIONAL,
INC. (“Dendrite”) and MARK THEILKEN (“Employee”).  Unless defined in the Amendment, capitalized
terms used in this Amendment will have the meaning set forth in the Employment
Agreement.

WHEREAS,
the Company and the Employee are parties to the Employment Agreement and wish
to amend the Employment Agreement; and

WHEREAS,
the Company considers it essential to the best interests of its shareholders to
foster the continuous employment of key management;

NOW
THEREFORE, in consideration of the premises and mutual covenants contained in
this Amendment, the Company and the Employee agree as follows:

1.             Section 4(b) of the Employment
Agreement is deleted and replaced as follows:

If your employment hereunder is terminated by Dendrite for any reason
other than death, Cause (as defined in Exhibit A), or Disability (as defined in
Exhibit A), you shall be entitled to receive severance payments of your monthly
base salary for 12 months following your employment termination (calculated at
the rate of base salary then being paid to you as of the date of termination)
and your Final Annual Target Bonus (as defined below Section 4(g)).  The severance payments to be paid to you
under this Section 4(b) shall be referred to herein as the “Severance Payment.”  The Severance Payment shall be paid to you in
twelve consecutive equal monthly payments commencing in the payroll period
following the date you sign the separation agreement described in Section 4(d)
below.  No interest shall accrue or be
payable on or with respect to any Severance Payment.  In the event of a termination of your
employment described in this Section 4(b), you shall be provided continued “COBRA”
coverage pursuant to Sections 601 et seq. of ERISA under Dendrite’s group
health plan.  During the period which you
receive the Severance Payment, your cost of COBRA coverage shall be the same as
the amount paid by employees of Dendrite for the same coverage under Dendrite’s
group health plan.  Notwithstanding the
foregoing, in the event you become re-employed with another employer and become
eligible to receive health coverage from such employer, the payment of COBRA
coverage by Dendrite as described herein shall cease.  You agree to notify Dendrite of any full-time
employment that you begin while receiving the Severance Payment.

2.             A new Section 4(g) is added to the
Employment Agreement as follows:

Final Annual Target Bonus means the annual target
bonus established for you in the fiscal year in which your employment
terminates, or, if the annual target bonus has not been established for you in
such fiscal year, then the annual target bonus for the prior fiscal year shall
be used.

3.             Except
as expressly modified by this Amendment, all of the terms and conditions of the
Employment Agreement shall remain in full force and effect.

IN WITNESS
WHEREOF, the parties have signed this Amendment as of the first date written
above.

DENDRITE
INTERNATIONAL, INC.

	
  

  	
  By:

  	
  /s/ Christine A. Pellizzari

  
	
   

  	
  Name:

  	
  Christine A. Pellizzari

  
	
   

  	
  Title:

  	
  Sr. Vice President, General Counsel and Secretary

  
	
   

  	
  Date:

  	
  November ___, 2006

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ Mark Theilken

  
	
   

  	
  Name:

  	
  Mark Theilken

  
	
   

  	
  Date:

  	
  November     , 2006Exhibit
10.66

AMENDMENT

THIS AMENDMENT is made as of
March 1, 2007 and amends the Employment Agreement dated as of April 2, 2004, as
amended through February 13, 2006  (the “Employment
Agreement”) between DENDRITE INTERNATIONAL,
INC. (“Dendrite”) and MARK THEILKEN (“Employee”).  Unless defined in this Amendment, capitalized
terms used in this Amendment will have the meaning set forth in the Employment
Agreement.

WHEREAS, the Company and the Employee are parties to
the Employment Agreement and wish to amend the Employment Agreement; and

WHEREAS, the Compensation Committee of the Board has
determined it to be in the best interests of the Company and its shareholders
for the Company to commit to certain executives of the Company facing potential
excise tax liability, that certain payments shall be made in the event such
liability exists upon the consummation of any Change of Control;

NOW, THEREFORE, in consideration of the premises and
mutual covenants contained in this Amendment, the Company and the Employee agree
as follows:

1.             Section 4(f) of
the Employment Agreement is restated in its entirety to provide as follows:

“(f)          Notwithstanding anything else herein
to the contrary, in the event that the Company’s certified public accountants
(or another of the “big four” certified public accounting firm, if the Company’s
certified public accountants may not provide such service due to independence
or other considerations) (the “Accountants”) determine that any actual or
potential payment or distribution by the Company to or for the benefit of the
Employee (whether paid, payable, distributed or distributable to the Employee,
whether under this Agreement or otherwise) (a “Payment”) would likely subject
the Employee to the imposition of an excise tax under Section 4999 of the Code
(or any similar successor provision) (“Section 4999”), then the Company shall
pay to the Employee an amount (the “Tax Gross-Up Payment”), to be calculated by
the Accountants, designed and calculated to fully negate the tax impact of any
excise tax and any potential interest or penalties related thereto and any
expenses incurred attributable to any claim contest or notice of alleged
deficiency or alleged underpayment imposed (or to be imposed) upon the Employee
as a result of Section 4999.  Any such
Tax Gross-Up Payment will take into account the federal, state and local
income, employment and excise tax consequences of the Tax Gross-Up Payment,
including the additional impact of Section 4999 on the Tax Gross-Up Payment
itself.  The Employee shall be deemed to
pay federal, state and local taxes at the highest marginal rate of taxation for
the applicable calendar year.  The
estimated Tax Gross-Up Payment due the Employee with respect to any Payment
shall be paid to the Employee in a lump sum not later than thirty (30) business
days after such Payment is provided to the Employee.  In the event that the Tax Gross-Up Payment is
less than the amount actually due to the Employee under this Section 4(f) the
amount of any such shortfall, plus applicable additional interest or penalties
related thereto and any expenses incurred attributable to any claim contest or
notice of alleged deficiency or alleged underpayment, shall be paid to the
Employee within ten (10) days after the existence of the shortfall is discovered.  In the event the Tax Gross-Up Payment is more

than
the amount actually due the Employee under this Section 4(f), the Employee
shall repay the amount of such overpayment to the Company within a reasonable
time after the overpayment is discovered.”

2.             Except
as expressly modified by this Amendment, all of the terms and conditions of the
Employment Agreement shall remain in full force and effect.

IN WITNESS WHEREOF, the
parties have signed this Amendment as of the first date written above.

DENDRITE INTERNATIONAL,
INC.

	
  

  	
   

  	
  /s/ Christine Pellizzari

  
	
   

  	
  Name:

  	
  Christine Pellizzari

  
	
   

  	
  Title:

  	
  Senior Vice President, General Counsel and Secretary

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ Mark
  Theilken

  
	
   

  	
  Mark TheilkenExhibit
10.67

[Dendrite Logo]

1405 US Highway 206,
Bedminster, NJ 07921 USA

September 19, 2006

James Young

[ADDRESS]

 

Dear Jim,

We would like to
confirm the terms and conditions of your employment with Dendrite International,
Inc. (“Dendrite”).

SPECIFIC TERMS & CONDITIONS
OF EMPLOYMENT

1.             DUTIES/TERM. You will be
employed as SVP and Chief Human Resources Officer initially reporting to Joe Ripp. You shall (i) perform those duties as may from
time to time be assigned to you by Dendrite or its affiliates; (ii) devote your
full-time attention and best efforts solely and exclusively to the duties
assigned to you; and (iii) comply with all existing Dendrite rules,
regulations, policies and directives and those which may be established from
time to time. Your employment will be at-will and may be terminated at any time
for any reason with or without cause by Dendrite. You agree to provide two (2)
weeks notice to Dendrite before terminating your employment.

2.             COMPENSATION.

(a)           Base Salary. Dendrite shall
pay you for your services an initial base salary at a rate of $250,000 per
annum to be paid on a semi-monthly basis in accordance with Dendrite’s regular payroll
practices. Any salary increases will be evaluated no less frequently than on
the anniversary date of your employment, provided this in no way guarantees you
any salary increase.

(b)           Bonus.
You will be eligible to receive an annual discretionary bonus (the “Bonus”)
with an initial target of $150,000. Bonus eligibility shall be determined and
paid in accordance with Dendrite’s applicable incentive compensation policy in
effect for senior executives. They payment of any Bonus is subject to: (a)
Dendrite’s achievement of quarterly and annual financial goals as set forth in
the Board approved annual business plan, (b) such other objectives as may be
determined by Dendrite from

 1
 

time to time, (c) you remaining in the employ of
Dendrite as of the time of payment of any such Bonus, and (d) the terms and
conditions of the applicable incentive compensation plan in effect from time to
time. Your target for a discretionary bonus will be reviewed and determined on
an annual basis by Dendrite. Nothwithstanding the foregoing, the Company shall
pay you a 2006 bonus calculated as follows: $150,000 times a fraction the
numerator of which is the number of days you are employed by Dendrite in 2006
and the denominator of which is 365, provided that you are employed by Dendrite
and have not given notice of your resignation on the date that Dendrite pays
such 2006 Bonus. In addition, notwithstanding the foregoing, the Company shall
pay you a minimum $75,000 bonus for 2007, provided that you are employed by
Dendrite and have not given notice of your resignation on the date that
Dendrite pays such a 2007 Bonus. Bonuses shall be paid no later than March 31
of the following year.

(c)           Stock
Options. Pursuant to the Dendrite’s New Hire Stock Plan (the “Stock Plan”),
upon the execution of this Agreement, you shall be eligible to receive
non-qualified options to purchase 60,000 shares of the common stock of Dendrite.
The price for such options shall be determined by the Compensation Committee of
the Board, subject to the terms and conditions of the Stock Plan. You will be
eligible for subsequent discretionary option grants at times that other senior
executives are eligible for such grants. Your entitlement to any options shall
be subject to (i) a four-year vesting schedule, (ii) approval by the Board,
(ii) your execution of a definitive option agreement in form and substance
satisfactory to Dendrite, and (iv) in all instances subject to the terms and
conditions of the Stock Plan.

(d)           Sign-On
Bonus. You will also receive a sign-on bonus of $50,000, payable within thirty
(30) days of your start date. In the event that prior to the first anniversary
of your employment (i) you voluntarily terminate your employment with Dendrite
for any reason whatsoever, or (ii) your employment is terminated by Dendrite
for Cause, you agree to pay to Dendrite within 90 days of the termination of
your employment an amount equal to (i) the sign-on bonus multiplied by (ii) a
fraction, the numerator of which is 365 minus the number of days that you are
employed by Dendrite and the denominator of which is 365. You authorize
Dendrite to immediately offset against and reduce any amounts otherwise due you
for any amounts in respect of your obligation to repay the sign-on bonus. The
foregoing shall not apply in the event of a Change in Control (as defined in
Exhibit A).

3.             BENEFITS.

Dendrite shall provide you:

(a)           Vacation.
Four (4) weeks vacation per annum in accordance with Dendrite policy in effect
from time to time.

 2
 

(b)         Business Expenses.
Reimbursement for reasonable travel, entertainment and other reasonable and
necessary out-of-pocket expenses incurred by you in connection with the
performance of your duties in accordance with Dendrite policy in effect from
time to time.

(c)          Retirement Benefits.
Retirement benefits to the same extent as may be provided to other similarly
situated senior executives in accordance with Dendrite policy then in effect
and subject to the terms and conditions of any such benefits plans.

(d)         Other. Other
benefits to the same extent as may be provided to other senior executives in
accordance with the Dendrite policy in effect from time to time and subject to
the terms and conditions of such benefit plans. For the avoidance of doubt,
Dendrite shall not, at this time, reimburse you for any commuting or relocation
expenses.

4.             SEVERANCE.

(a)           If
your employment hereunder is terminated by Dendrite for any reason other than
termination by Dendrite for Cause (as defined in Exhibit A), Disability (as
defined in Exhibit A) or upon your death, you shall solely be entitled to
(subject to any applicable off-sets) applicable payments and benefits in
Section 4(b) or 4(c) and your base salary through the date of your termination.

(b)           If
your employment hereunder is terminated by Dendrite for any reason other than
death, Cause (as defined in Exhibit A), or Disability (as defined in Exhibit
A), you shall be entitled to receive severance payments of your monthly base
salary for 12 months following your employment termination (calculated at the
rate of base salary then being paid to you as of the date of termination) and
your Final Annual Target Bonus (as defined below in Section 4(f)). The
severance payments to be paid to you under this Section 4(b) shall be referred
to herein as the “Severance Payment.” The Severance Payment shall be paid to
you in twelve consecutive equal monthly payments commencing in the payroll
period following the date you sign the separation agreement described in
Section 4(e) below. No interest shall accrue or be payable on or with respect
to any Severance Payment. In the event of a termination of your employment described
in this Section 4(b), you shall be provided continued “COBRA” coverage pursuant
to Sections 601 et seq. of ERISA under Dendrite’s group health plan. During the
period which you receive the Severance Payment, your cost of COBRA coverage
shall be the same as the amount paid by employees of Dendrite for the same
coverage under Dendrite’s group health plan. Nothwithstanding the foregoing, in
the event you become re-employed with another employer and become eligible to
receive health coverage from such employer, the payment of COBRA coverage by
Dendrite as described herein shall cease. You agree to notify Dendrite of any
full-time employment that you begin while receiving the Severance Payment.

 3
 

(c)           The
following severance payment only applies in the event of a Change in Control
(as defined in Exhibit A). If, within the one (1) year period following a
Change in Control, your employment hereunder (i) is terminated by Dendrite or
its successor for any reason other than Cause or Disability, or as a result of your
death, or (ii) voluntarily by you with Good Reason (as defined in Exhibit A),
then you shall be entitled to receive a severance payment equal to the sum of
twenty-four (24) months base salary (calculated at the rate of base salary then
being paid to you as of the date of termination) plus two (2) times your Final
Annual Target Bonus (as defined below in Section 4(f)). The severance payments
to be paid to you under this Section 4(c) shall be referred to as the “Change
in Control Severance Payment.” Your Change in Control Severance Payment shall
be paid to you in a lump-sum no later than twenty (20) days after the date you
sign the separation agreement described in Section 4(e) below. No interest
shall accrue or be payable on or with respect to any Change in Control
Severance Payment. In the event of a termination of your employment described
in this Section 4(c), you shall be provided continued “COBRA” coverage pursuant
to Sections 601 et seq. of ERISA (or COBRA-like coverage if COBRA does not or
would no longer apply) under Dendrite’s group health plan for the twenty-four
(24) month period commencing on the date of termination of employment. During
the period in which you receive such coverage, your cost of coverage shall be
the same as the amount paid by employees of Dendrite for the same coverage
under Dendrite’s group health plan. Notwithstanding the foregoing, in the event
you become re-employed with another employer and become eligible to receive
health coverage from such employer, the payment of COBRA coverage by Dendrite
as described herein shall cease. You agree to notify Dendrite of any full-time
employment that you begin while receiving the Change in Control Severance
Payment. In the event of a Change in Control, all equity awards and stock options
then granted to you by Dendrite will immediately vest and all sales
restrictions will be lifted.

(d)           For
purposes of clarification, under no circumstances are you entitled to receive
payments under both Sections 4(b) and 4(c), and you will not be entitled to any
other severance payments from Dendrite.

(e)           The
making of any Severance Payments or Change in Control Severance Payments, and
the provision of benefits under Sections 4(b) or 4(c) hereunder, is conditioned
upon the signing of a general release in form and substance satisfactory to
Dendrite under which you release Dendrite and its affiliates together with
their respective officers, directors, shareholders, employees, agents and
successors and assigns from any and all claims you may have against them. In
the event you breach any

 4
 

provisions of Sections 1 through 6 of the General
Terms and Conditions of Employment of this Agreement, in addition to any other
remedies at law or in equity, Dendrite may cease making any Severance Payment,
Change in Control Severance Payment, or any payments for COBRA coverage
otherwise due under Sections 4(b) or 4(c). Nothing herein shall affect any of
your obligations or Dendrite’s rights under this Agreement.

(f)            Final
Annual Target Bonus means the annual target bonus established for you in the
fiscal year in which your employment terminates, or, if the annual target bonus
has not been established for you in such fiscal year, then the annual target
bonus for the prior fiscal year shall be used; provided
that, in connection with a Change in Control Severance Payment, in
no event shall the Final Annual Target Bonus be less than the annual target
bonus most recently established for you prior to the occurrence of the Change
in Control.

(g)           Nothwithstanding
the foregoing, any payments under this Section 4 may be delayed, for no more
than six (6) months following termination of your employment, pursuant to
Section 409A of the Internal Revenue Code (the “Code”), and, to the extent such
severance payment shall accrue from the date otherwise scheduled for such
payment under the terms of this agreement until the date of actual payment at
an annual rate of six percent (6%).

Please sign where indicated below to acknowledge your
agreement to the Specific Terms and Conditions (“Special Terms”) set forth
above and the General Terms and Conditions of Employment attached hereto (“General
Terms”), both of which together shall form the terms and conditions of your
employment (the “Agreement”).

	
  

  	
   

  	
  Sincerely,

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ Christine A. Pellizzari

  
	
   

  	
   

  	
  Christine A.
  Pellizzari

  
	
   

  	
   

  	
  Senior Vice
  President, General Counsel

  
	
   

  	
   

  	
  and Secretary

  
	
  Accepted and
  agreed to:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  /s/ James Young

  	
   

  	
   

  
	
  James Young

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Date:

  	
  9/26/2006

  	
   

  	
   

  
				

 

 

 5

DENDRITE INTERNATIONAL, INC.

GENERAL TERMS & CONDITIONS OF
EMPLOYMENT

(together
with the Specific Terms and Conditions of Employment, the “Agreement”)

1.             INFORMATION AND BUSINESS OPPORTUNITY.
During your employment with Dendrite, you may acquire knowledge of (i)
information that is relevant to the business of Dendrite or its affiliates or
(ii) knowledge of business opportunities pertaining to the business in which
Dendrite or its affiliates are engaged. You shall promptly disclose to Dendrite
that information or business opportunity but shall not disclose it to anyone
else without Dendrite’s written consent.

2.             DENDRITE AND CLIENT CONFIDENTIAL INFORMATION.
As a result of your employment with Dendrite, you will acquire information
which is proprietary and confidential to Dendrite and its affiliates. This
information includes, but is not limited to, Dendrite’s proprietary software,
technical and commercial information, instruction and product information, the
design, “look and feel” and capabilities of Dendrite’s product, Dendrite’s
proprietary training program methodology regarding the utilization of
electronic territory management software and associated client support
services, Dendrite’s methodology for prompting its products and services to its
clients, Dendrite’s proprietary Graphic User Interface, the navigational paths
through which Dendrite’s clients input and access information stored in the
proprietary software, the particularized needs and demands of Dendrite’s
clients and the customizations Dendrite makes to its proprietary software to
meet those clients’ needs, financial arrangements, salary and compensation
information, competitive status, pricing policies, knowledge of suppliers,
technical capabilities, discoveries, algorithms, concepts, software in any
stage of development, designs, drawings, specifications, techniques, models,
data, technical manuals, training guides and manuals, research and development
materials, processes, procedures, know-how and other business affairs relating
to Dendrite. Confidential information also includes any and all technical
information involving Dendrite’s work. In addition, Dendrite may be furnished
information and data which is proprietary and confidential to its clients,
partners, suppliers and other third parties (“Third Parties”). You agree to use
the confidential information of Dendrite and Third Parties solely during and in
furtherance of your employment with Dendrite. You agree to keep all such
information confidential and agree not to reveal it at any time without the
express written consent of Dendrite. This obligation is to continue in force
after employment terminates for whatever reason.

3.             RETURN OF PROPERTY. Upon
termination of employment for any reason or upon the request of Dendrite, you
shall fully account for and return to Dendrite all property which you received,
prepared or helped prepare in connection with your employment including, but
not limited to, all copies of any confidential information or records, data,
materials, disks, notes, notebooks, blueprints, client lists or other papers or
material in any tangible media or computer readable form belonging to Dendrite
or to any of its clients, partners and suppliers. You will not retain any
copies, duplicates, reproductions or excerpts thereof.

 1
 

4.             INVENTIONS. All work performed
by you and all materials, products, deliverables, inventions, software, ideas,
disclosures and improvements, and copyrighted material made or conceived by
you, solely or jointly, in whole or in part, during your employment with
Dendrite (even if completed following the termination of your employment) that
relate to any matters pertaining to the business of Dendrite shall be the
property of Dendrite and shall be deemed to be a work made for hire. To the
extent that title to any of the foregoing shall not, by operation of law, vest
in Dendrite, all right, title and interest therein are hereby irrevocably
assigned to Dendrite. You agree to give Dendrite or any person on entity
designated by Dendrite reasonable assistance required to perfect its rights
therein.

5.             RESTRICTION ON FUTURE EMPLOYMENT.
You acknowledge (i) the highly competitive nature of the business and the
industry in which Dendrite competes; (ii) that you will acquire and have access
to confidential information as described in Section 2 of the General Terms;
(ii) that, as a key employee of Dendrite, you will participate in the servicing
of current clients and/or the solicitation of prospective clients, through
which among other things, you will obtain knowledge of the “know-how” and
business practices of Dendrite, in which matters Dendrite has a substantial
proprietary interest; and (iv) that your employment hereunder requires the
performance of services which are special, unique, extraordinary and
intellectual in character, and your position with Dendrite places you in a
position of confidence and trust with the clients and  employees of Dendrite. In the course of your
employment with Dendrite, you will develop a personal relationship with the
clients of Dendrite and a knowledge of those clients’ affairs and requirements,
and that the relationship of Dendrite with their established clientele will
therefore be placed in your hands in confidence and trust. You consequently
agree that it is reasonable and necessary for the protection of the
confidential information, goodwill and business of Dendrite that you make the
covenants contained herein and that Dendrite would not have entered into this
Agreement unless the covenants set forth in this Section 5 were contained in
this Agreement. Accordingly, you agree that during the period that you are
employed by Dendrite and for a period of eighteen (18) months thereafter, you
shall not, as an individual, employee, consultant, partner, shareholder, or in
association with any other person, business or enterprise, except on behalf of
Dendrite, directly or indirectly, and regardless of the reason for your ceasing
to be employed by Dendrite:

(a)           perform
services that compete with the business or business conducted by Dendrite or
any of its affiliates or render services to any person or entity which competes
with the business of businesses conducted by Dendrite or any of its affiliates
(of which business Dendrite can at the time of your termination of employment
establish it will likely conduct within one (1) year following the date of your
termination);

(b)           attempt
in any manner to solicit or accept from any client business of the type
performed by Dendrite or to persuade any client to cease to do business or to
reduce the amount of business which any such client has customarily done or is
reasonably

 2
 

expected to do with Dendrite, whether or not the relationship between
Dendrite and such client was originally established in whole or in part through
your efforts;

(c)           employ,
attempt to employ or assist anyone else in employing any employee or contractor
of Dendrite or induce or attempt to induce any employee or contractor of
Dendrite to terminate their employment or engagement with Dendrite; or

(d)           render
to or for any client any services of the type rendered by Dendrite (unless such
services are rendered directly to a client as an employee of such client, in
which case this Section 5(d) shall not apply).

As used in this
Section 5, the term “Dendrite” shall mean Dendrite and its affiliates, and the
term “client” shall mean (1) anyone who is a client of Dendrite on the date of
your termination or, if your employment shall not have terminated, at the time
of the alleged prohibited conduct (any such applicable date being called the “Determination
Date”), but only if you solicited, rendered services for, or were otherwise
involved with any such client at any time during your employment with Dendrite;
(2) anyone who was a client of Dendrite at any time during the one (1) year
period immediately preceding the Determination Date; but only if you solicited,
rendered services for, or were otherwise involved with any such client at any
time during your employment with Dendrite; (3) any prospective client to whom
Dendrite had made a new business presentation (or similar offering of services)
at any time during the one (1) year period immediately preceding the
Determination Date; but only if you actively participated in or supervised such
new business presentation (or similar offering of services); and (4) any
prospective client to whom Dendrite made a new business presentation (or
similar offering of services) at any time within six (6) months after the date
of your termination (but only if the initial discussions between Dendrite and
such prospective client relating to the rendering of services occurred prior to
the date of your termination, and only if you actively participated in or
supervised such discussions). For purposes of this clause, it is agreed that a
general mailing or an incidental contact shall not be deemed a “new business
presentation or similar offering of services” or a “discussion”. In addition,
if the client is part of a group of companies which conducts business through
more than one entity, division or operating unit, whether or not separately
incorporated (a “Client Group”), the term “client” as used herein shall also
include each entity, division and operating unit of the Client Group where the
same management group of the Client Group has the decision making authority or
significant influence with respect to contracting for services of the type
rendered by Dendrite.

For an eighteen
(18) month period after the termination of your employment for any reason
whatsoever, you agree to promptly notify Dendrite in writing the identity of
all subsequent employers. You agree to provide such information as Dendrite may
from time to time request to determine your compliance with the terms of this
Agreement.

 3
 

6.             NON-DISPARAGEMENT. You agree
that you will not at any time make any statement, observation or opinion, or
communicate any information (whether oral or written) that is likely to come to
the attention of any client or employee of Dendrite or any member of the media,
which statement is derogatory of or casts in a negative light Dendrite or its officers,
directors and employees or otherwise engage in any activity which is inimical
to the interests of the Company.

7.             OUTSIDE CONTRACTING. You shall
not enter into any agreements to provide services to any company, person or
organization outside of your employment by Dendrite (an “Outside Agreement”)
without the prior written express consent from Dendrite. You must notify
Dendrite of your intent to enter into an Outside Agreement specifying therein
the other party to such Outside Agreement and the type of services to be
provided by you. Dendrite shall not unreasonably withhold permission to you to
enter into Outside Agreements unless such Outside Agreements (i) are with
competitors or potential competitors of Dendrite, or (ii) as determined in
Dendrite’s sole discretion, shall substantially hamper or prohibit you from
satisfactorily carrying out all duties assigned to you by Dendrite.

8.             REMEDIES. The parties agree
that in the event you breach or threaten to breach this Agreement, money
damages may be an inadequate remedy for Dendrite and that Dendrite will not
have an adequate remedy at law. It is understood, therefore, that in the event
of a breach or threatened breach of this Agreement by you, Dendrite shall have
the right to obtain from a court of competent jurisdiction restraints or
injunctions prohibiting you from breaching or threatening to breach this
Agreement. In that event, the parties agree that Dendrite will not be required
to post bond or other security. It is also agreed that any restraints or
injunctions issued against you shall be in addition to any other remedies which
Dendrite may have available to it.

9.             ARBITRATION

(a) If any dispute
arises between you and Dendrite that the parties cannot resolve themselves,
including any dispute over the application, validity, construction, or
interpretation of this Agreement, arbitration in accordance with the
then-applicable employment law rules of the American Arbitration Association
shall provide the exclusive remedy for resolving any such dispute, regardless
of its nature; provided, however, that Dendrite may enforce your obligation to
provide services under this Agreement and your obligations under Sections 1
through 7 hereof by an action for injunctive relief and damages in a court of
competent jurisdiction at any time prior or subsequent to the commencement of
an arbitration proceeding as herein provided. This Section 9 shall apply to any
and all claims arising out of your employment and its termination, under state
and federal statues, local ordinances, and the common law including, without
limitation Title VII of the Civil Rights Act of 1964, as amended, the Civil
Rights Act of 1991, the Equal Pay Act, the Employee Retirement Income Security
Act, as amended, the Age Discrimination in Employment Act of 1967, the
Americans with Disabilities Act of 1990, the Family and Medical Leave Act of
1993, the Fair Labor Standards Act, the New Jersey Family

 4
 

Leave Act, the New Jersey
Conscientious Employee Protection Act, the New Jersey Civil Rights Act and the
New Jersey Law Against Discrimination.

(b) You
have read and understand this Section 9 which discusses arbitration.  You understand that by signing this
Agreement, you agree to submit any claims arising out of, relating to, or in
connection with this Agreement, or the interpretation, validity, construction,
performance, breach or termination thereof, or your employment or the
termination thereof, to binding arbitration, and that this arbitration
provision constitutes a waiver of your right to a jury trial and relates to the
resolution of all disputes relating to all aspects of the employer/employee
relationship.  You further understand
that other options such as federal and state administrative remedies and
judicial remedies exist and know that by signing this Agreement those remedies
are forever precluded and that regardless of the nature of your complaint, you
know that it can only be resolved by arbitration.

(c) Unless the
parties agree otherwise, any arbitration shall be administered by and take
place in the offices of the American Arbitration Association in Somerset, New
Jersey.  If that office is not available,
the arbitration then the arbitrator shall determine the location of the
arbitration within New Jersey.

10.          SEVERABILITY. If any provision of
this Agreement shall be declared invalid or illegal for any reason whatsoever,
then notwithstanding such invalidity or illegality, the remaining terms and
provisions of this Agreement shall remain in full force and effect in the same
manner as if the invalid or illegal provisions had not been contained
herein.  Moreover, if any one or more of
the provisions contained in this Agreement is held to be excessively broad as
to duration, scope, activity or subject, such provisions will be construed by
limiting and reducing them so as to be enforceable to the maximum extent
compatible with applicable law.

11.          NOTICES. In the event any notice
is required to be given under the terms of this Agreement, it shall be
delivered in the English language, in writing, as follows:

 

	
  If to you:

  	
  To the address set forth on the first page of this
  Agreement

  
	
   

  	
   

  
	
  If to Dendrite:

  	
  Attn: General Counsel

  
	
   

  	
  Dendrite International, Inc.

  
	
   

  	
  1405 Route 206 South

  
	
   

  	
  Bedminster, NJ 07921

  

 

or to such other address
as either party may have furnished to the other in writing in accordance
herewith, except that notices of changes of address shall be effective only
upon receipt.

12.          PRIOR EMPLOYMENT. You represent
and warrant that you have not taken or otherwise misappropriated and do not
have in your possession or control any confidential and

 5
 

proprietary information
belonging to any of your prior employers or connected with or derived from your
service to prior employers. You represent and warrant that you have returned to
all prior employers any and all such confidential and proprietary
information.  You further acknowledge,
represent and warrant that Dendrite has informed you that you are not to use or
cause the use of such confidential or proprietary information in any manner
whatsoever in connection with your employment by Dendrite. You agree, represent
and warrant that you will not use such information.  You shall indemnify and hold harmless
Dendrite from any and all claims arising from any breach of the representations
and warranties in this Section.

13.          MISCELLANEOUS.

(a)           This Agreement shall be governed by and
construed in accordance with the laws of New Jersey, without regard to the
conflicts of laws. Competent courts of jurisdiction in New Jersey shall have
exclusive jurisdiction to entertain any legal or equitable action with respect
to Section 1 through 8 of the General Terms except that Dendrite may institute
any such suit against you in any jurisdiction in which you may be at the time.
In the event suit is instituted in New Jersey, it is agreed that service of
summons or other appropriate legal process may effected upon any party by
delivering it to the last known address.

(b)           Your rights or obligations under the
terms of this Agreement or of any other agreement with Dendrite may not be
assigned. Any attempted assignment will be void as to Dendrite. Dendrite may,
however, assign its rights to any affiliated or successor entity.

(c)           This Agreement sets forth the entire
agreement between the parties hereto and fully supersedes any and all prior
negotiations, discussions, agreements or understandings between the parties
hereto pertaining to the subject matter hereof. No representations, oral or
otherwise, with respect to the subject matter of this Agreement have been made
by either party. This Agreement may not be modified or waived except by a
writing signed by both parties. No waiver by either party of any breach by the
other shall be considered a waiver of any subsequent breach of the Agreement.

(d)           This Agreement shall be binding upon
and inure to the benefit of your heirs and personal representatives and to the
successors and assigns of Dendrite.

 6

Exhibit A
To Dendrite Specific Terms & Conditions Of Employment

(a)           “Cause” as used in this Agreement
shall mean (i) any gross misconduct on the part of you with respect to your
duties under this Agreement, (ii) the engaging by you in an indictable offense
which relates to your duties under this Agreement or which is likely to have a
material adverse effect on the business of Dendrite, (iii) the commission by
you of any willful or intentional act which injures in any material respect or
could reasonably be expected to injure in any material respect the reputation,
business or business relationships of Dendrite, including without limitation, a
breach of Sections 1 through 7 of the General Terms and Conditions of
Employment, or (iv) the engaging by you through gross negligence in conduct
which injures materially or could reasonably be expected to injure materially
the business or reputation of Dendrite.

(b)           “Disability” as used in this
Agreement shall have the same meaning as that term, or such substantially equivalent
term, has in any group disability policy carried by Dendrite.  If no such policy exists, the term “Disability”
shall mean the occurrence of any physical or mental condition which materially
interferes with the performance of you customary duties in your capacity as an
employee where such disability has been in effect for a person of six (6)
months (excluding permitted vacation time), which need not be consecutive,
during any single twelve (12) month period.

(c)           “Good Reason” as used in this Agreement
shall mean, without your express written consent, the occurrence of any of the
following events concurrently with or within one (1) year following a “Change
in Control” (as defined below) which is not corrected within ten (10) days
following written notice of such event given by you to Dendrite:

(i)            the
assignment to you of any duties or responsibilities materially and adversely
inconsistent with your position (including any material diminution of such
duties or responsibilities) or (B) a material and adverse change in your
reporting responsibilities, titles or offices with Dendrite;

(ii)           any
material breach by Dendrite this Agreement with respect to the making of any
compensation payments;

(ii)           any
requirement of Dendrite that you be based anywhere other than in a thirty-five
(35) mile radius of  the Dendrite office
you are based in on the date of the consummation of the Change in Control.

(iv)          the
failure of Dendrite to continue in effect any employee benefit plan,
compensation plan, welfare benefit plan or fringe benefit plan (such plans
being referred to herein as “Welfare Plans”) in which you are participating as
of the date of this Agreement (or as such benefits and compensation may be
increased from time to time), or the taking of any action by Dendrite which
would materially and adversely affect your participation in or materially
reduce your benefits under such Welfare Plans (other than an across-the-board
reduction of such benefits affecting senior executives of Dendrite) unless (i)
you are permitted to participate in other plans providing you with
substantially

 1
 

comparable benefits (at substantially comparable cost with respect to
the Welfare Plans),  (ii)  any such Welfare Plan does not provide
material benefits to you (determined in relation to your compensation and
benefits package), (iii) such failure or action is taken at the direction of
you or with your consent, or (iv) such failure or action is required by law; or

(v)           the
failure of Dendrite to obtain an agreement from a successor employer to assume
Dendrite’s obligations under this Agreement in the event of a Change in
Control.

You must notify Dendrite
of any event constituting Good Reason within ninety (90) days following your
knowledge of its existence or such event shall not constitute Good Reason.

(d)           “Change in Control” as used in this
Agreement shall mean the occurrence of any one of the following events:

(i)            any
“person” (as such term is defined in Section 3(a)(9) of the Securities and
Exchange Act of 1934, as amended (the “Exchange Act”), and as used in Sections
13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a “beneficial owner”
(as defined in rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of Dendrite representing 33 1/3% or more of the combined voting
power of Dendrite’s then outstanding securities eligible to vote for the
election of the Board (the “Dendrite Voting Securities”); provided, however,  that the event described in this subsection
(i) shall not be deemed to be a Change in Control by virtue of any of the
following acquisitions: (A) by Dendrite or any subsidiary, (B) by any employee
benefit plan sponsored or maintained by Dendrite or any subsidiary, (C) by any
underwriter temporarily holding securities pursuant to an offering of such securities,
(D) pursuant to a Non-Control Transaction (as defined in subsection (iii)), or
(E) a transaction (other than one described in subsection (iii) below) in which
Dendrite Voting Securities are acquired from Dendrite, if a majority of the
Incumbent Board (as defined below) approves a resolution providing expressly
that the acquisition pursuant to this clause (E) does not constitute a Change
in Control under this subsection (i);

(ii)           individuals
who, on the date of this Agreement, constitute the Board (the “Incumbent Board”)
cease for any reason to constitute at least a majority thereof, provided that
any person becoming a director subsequent to such date, whose election or
nomination for election was approved by a vote of at least two-thirds of the
directors comprising the Incumbent Board (either by a specific vote or by
approval of the proxy statement of Dendrite in which such person is named as a
nominee for director, without objection to such nomination) shall be considered
a member of the Incumbent Board; provided, however, that no
individual initially elected or nominated as a director of Dendrite as result
of an actual or threatened election contest with respect to directors or any
other actual or threatened solicitation of proxies or consents by or on behalf
of any person other than the Board shall be deemed to be a member of the
Incumbent Board;

 2
 

(iii)          the
shareholders of Dendrite approve a merger, consolidation, share exchange or
similar form of corporate reorganization of Dendrite or any such type of
transaction involving Dendrite or any of its subsidiaries (whether for such
transaction or the issuance of securities in the transaction or otherwise) (a “Business
Combination”), unless immediately following such Business Combination:  (A) more than 50% of the total voting power
of the publicly traded corporation resulting from such Business Combination
(including, without limitation, any corporation which directly or indirectly
has beneficial ownership of 100% of Dendrite Voting Securities or all or
substantially all of the assets of Dendrite and its subsidiaries) eligible to
elect directors of such corporation would be represented by shares that were
Dendrite Voting Securities immediately prior to such Business Combination
(either by remaining outstanding or being converted), and such voting power
would be in substantially the same proportion as the voting power of such
Dendrite Voting Securities immediately prior to the Business Combination, (B)
no person (other than any publicly traded holding company resulting from such
Business Combination, any employee benefit plan sponsored or maintained by
Dendrite (or the corporation resulting from such Business Combination), or any
person which beneficially owned, immediately prior to such Business Combination,
directly or indirectly, 33-1/3% or more of Dendrite Voting Securities (a “Dendrite
33-1/3% Stockholder”)) would become the beneficial owner, directly or
indirectly, of 33-1/3% or more of the total voting power of the outstanding
voting securities eligible to elect directors of the corporation resulting from
such Business Combination and not Dendrite 33-1/3% Stockholder would increase
its percentage of such total voting power, and (C) at least a majority of the
members of the board of directors of the corporation resulting from such
Business Combination would be members of the Incumbent Board at the time of the
Board’s approval of the execution of the initial agreement providing for such
Business Combination (a “Non-Control Transaction”); or

(iv)          the
shareholder of Dendrite approve a plan of complete liquidation or dissolution
of Dendrite or the sale or disposition of all or substantially all of the
Dendrite’s assets.

Notwithstanding the
foregoing, a Change in Control of Dendrite shall not be deemed to occur solely
because any person acquires beneficial ownership of more than 33-1/3% of
Dendrite Voting Securities as result of the acquisition of Dendrite Voting
Securities by Dendrite which, by reducing the number of Dendrite Voting
Securities outstanding, increases the percentage of shares beneficially owned
by such person; provided, that, if a Change in Control of
Dendrite would occur as a result of such an acquisition by Dendrite (if not for
the operation of this sentence), and after Dendrite’s acquisition such person
becomes the beneficial owner of additional Dendrite Voting Securities that
increases the percentage of outstanding Dendrite Voting Securities beneficially
owned by such person, then a Change in Control of Dendrite shall occur.

 

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]